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PDZD8 can bind the capsid proteins of different retroviruses, and transient knockdown of PDZD8 results
in a decrease in the efﬁciency of an early, post-entry event in the retrovirus life cycle. Here we used the
CRISPR-CAS9 system to create cell lines in which PDZD8 expression is stably eliminated. The PDZD8-
knockout cell lines were infected by human immunodeﬁciency virus (HIV-1) and murine leukemia virus
as efﬁciently as the parental PDZD8-expressing cells. These results indicate that PDZD8 is not absolutely
necessary for HIV-1 infection and diminishes its attractiveness as a potential target for intervention.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The mature human immunodeﬁciency virus (HIV-1) contains a
conical capsid comprising 1500 capsid (CA) proteins, surrounding
the viral RNA genomes (Ganser et al., 1999). The CA protein of HIV-1 is
composed of N-terminal and C-terminal domains (NTD and CTD)
connected by a ﬂexible linker. The CA proteins oligomerize into
hexamers or pentamers by the interactions among the NTDs
(Pornillos et al., 2011). Interactions between the CTDs connect neigh-
boring hexamers, and the hexamer lattice is closed by pentamers to
form the capsid conical structure (Ganser-Pornillos et al., 2007).
After the entry of HIV-1 into host cells, viral capsids slowly
disassemble by a process of uncoating. Careful regulation of capsid
uncoating is essential for successful viral infection. Changes in HIV-1
capsid stability resulting from alteration of the CA protein or treatment
with small compounds signiﬁcantly attenuate viral reverse transcrip-
tion or nuclear import (Forshey et al., 2002; Shi et al., 2011).
Stability of the HIV-1 capsid can also be inﬂuenced by host cellular
proteins. The restriction factors TRIM5α and TRIMCyp bind and induce
premature uncoating of HIV-1 capsids (Stremlau et al., 2006; Sayah
et al., 2004). By contrast, if aberrantly located in the cytoplasm, the
nuclear protein CPSF6 can slow down capsid disassembly and inhibit
HIV-1 infection (Lee et al., 2010; Hori et al., 2013; Fricke et al., 2013). A
positive co-factor, cyclophilin A, a CA-binding prolyl isomerase, is
required for efﬁcient HIV-1 infection in some cell types and has been
implicated in capsid stabilization (Fricke et al., 2013; Li et al., 2009;
Hatziioannou et al., 2005).
The host protein PDZD8 was found to interact with the HIV-1 Gag
protein (Henning et al., 2010). Transient overexpression of PDZD8
enhanced HIV-1 infectivity, and transient knockdown of PDZD8
resulted in an approximately 10-fold reduction in the infection of cells
by HIV-1 and murine leukemia virus vectors (Henning et al., 2010;
Guth and Sodroski, 2014). Early post-entry events were affected
by transient PDZD8 knockdown (Henning et al., 2010; Guth and
Sodroski, 2014).
In considering a host protein as a target for intervention, one
desirable property is that knockdown or inhibition is tolerated by
the host, but results in a lasting and substantial disruption of virus
replication. Here, we evaluate PDZD8 as a potential target for
intervention in HIV-1 infection. Because antibodies to detect
endogenous PDZD8 were not previously available, the quantitative
dependency of HIV-1 infection on PDZD8 levels could not be
assessed in earlier studies (Henning et al., 2010; Guth and
Sodroski, 2014). Furthermore, indirect effects of transient PDZD8
knockdown could not be ruled out, particularly because PDZ
proteins typically associate with other proteins (Ye and Zhang,
2013). By generating antibodies that can detect endogenous
PDZD8 and by using CRISPR-CAS9 to knock out PDZD8 expression,
we rigorously evaluated the role of PDZD8 in HIV-1 infectivity. The
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PDZD8-negative cells supported infection by HIV-1 and murine
leukemia viruses as efﬁciently as the parent cells. These results
indicate that, at least in some contexts, PDZD8 is not required for
HIV-1 infection, thus diminishing the potential attractiveness of
PDZD8 as a target for HIV-1 intervention.
Results and discussion
To evaluate the contribution of PDZD8 to cell viability and HIV-1
infectivity, we wished to knock out the PDZD8 gene in cells using
CRISPR-CAS9. Because commercially available anti-PDZD8 antibodies
failed to detect endogenous PDZD8 in 293T cells (unpublished results),
we generated rabbit antiserum against human PDZD8. The PDZD8
proteins of humans and rabbits share more than 90% identity, so we
selected the most divergent region (amino acid residues 438–663) as an
immunogen (Supplementary Fig. 1). This sequence was expressed in E.
coli as a fusion protein with glutathione S-transferase (GST), which can
increase solubility and immunogenicity (Walls and Loughran, 2011). The
puriﬁed GST-PDZD8438–663 protein (Supplementary Fig. 2 and Fig. 1A)
was used to immunize two rabbits. Antisera from both immunized
rabbits detected the PDZD8-ﬂag protein expressed transiently in 293T
cells by Western blotting (Fig. 1B). To evaluate the ability of the rabbit
antisera to detect endogenous PDZD8, 293T and HeLa cells transfected
with PDZD8 siRNAs or negative control siRNAs were lysed and the cell
lysates Western blotted. Fig. 1C shows that the endogenous PDZD8
protein could be detected by Western blotting. The expression of
endogenous PDZD8 was reduced by the PDZD8-speciﬁc siRNAs. Both
antisera were also able to precipitate endogenous PDZD8 from 293T
cells (Fig. 1D).
Modiﬁcation of host genes encoding HIV-1 cofactors is useful to
assess their role in the viral life cycle and may eventually prove to
be applicable in interventions (Dai et al., 2013; Kim et al., 2009;
Tebas et al., 2014). Advances in gene editing by the CRISPR-CAS9
technology have made the manipulation of target genes simpler
(Hsu et al., 2014). Although the CRISPR-CAS9 system has a low
efﬁciency of gene disruption, the insertion of selectable markers
into the target genes can help in screening (Cong et al., 2013; Hou
et al., 2013). To knock out pdzd8 gene expression completely in
293T and HeLa cells, protospacer sequences were selected in
regions close to the start codon. As highly condensed regions of
the chromosome may decrease the efﬁciency of CRISPR-CAS9
access to the gene, we selected DNase1-sensitive target regions
and used multiple protospacer sequences to increase the success
rate. Three protospacer sequences were selected, and the corre-
sponding oligonucleotides were synthesized, annealed and ligated
to the digested pX330 vector according to the CRISPR-cloning
protocol described in the Materials and Methods (Fig. 2A). The
homology arm was ampliﬁed by PCR from nucleotides 1107 to
866 of the pdzd8 gene (where the ﬁrst base of the pdzd8 open
reading frame is considered þ1, and the upstream sequence,
starting with 1, is designated in reverse order). A BamHI
restriction site was introduced between the 1 and þ1 positions
by site-directed PCR mutagenesis, and a GFP-2A-Puromycin cas-
sette was cloned into this site (Fig. 2A). The linearized homology
arm containing the GFP-2A-Puromycin cassette was cotransfected
with pX330-gRNA1, 2 or 3 into 293T and HeLa cells. Puromycin-
resistant cells were selected, but only a small percentage of these
detectably expressed GFP. To examine whether PDZD8 expression
was altered in the transfected cells, cell lysates were Western
blotted with the rabbit anti-PDZD8 antisera. Only the pX330-
gRNA1 abolished PDZD8 expression in both 293T and HeLa cells
(Fig. 2B). Clones of 293T cells transfected with pX330-gRNA1 were
obtained by serial dilution and examined for PDZD8 expression by
Western blotting. PDZD8 expression in these 293T clones was
below detectable levels (Fig. 2C). The pdzd8 gene of seven clones
was ampliﬁed by PCR and sequenced. Representative results from
two clones are shown in Fig. 2D. PDZD8 knockout (KO) clone
1 sustained a deletion of 11 base pairs. PDZD8 KO7 exhibited
random insertions and deletions in the pdzd8 gene, indicative of
non-homologous end-joining. No GFP-2A-Puromycin sequences
were found in the pdzd8 genes, suggesting that the observed
puromycin resistance may have resulted from insertion of either
the complete or partial GFP-2A-Puromycin cassette into other
genomic sites.
The growth and viability of the PDZD8 KO cells were indis-
tinguishable from those of the parent cell lines (unpublished
observations). To examine the effect of PDZD8 knockout on retro-
viral infection in 293T and HeLa cells, PDZD8 KO cells were
incubated with different doses of recombinant HIV-1 and MLV
vectors pseudotyped with the vesicular stomatitis virus G glyco-
protein and expressing GFP (Fig. 3). Two days afterwards, GFP
expression in the target cells was measured as a marker of virus
infection. No signiﬁcant difference was observed between the
levels of either HIV-1 or MLV infection of parental 293T or HeLa
cells and the respective PDZD8 KO cells. Apparently, PDZD8 is not
required for efﬁcient infection of these cells by HIV-1 or MLV.
PDZD8 was implicated as a potential regulator of early events in
the retrovirus infection cycle in CHME3, a microglial cell line, and
in HeLa cells, using overexpression or siRNA-mediated transient
knockdown of PDZD8 (Henning et al., 2010; Guth and Sodroski,
2014). These experiments leave open the possibility that transient
variation in PDZD8 levels indirectly affects other moieties (e.g.,
moesin) (Haedicke et al., 2008; Naghavi et al., 2007; Henning et al.,
2011) implicated in retrovirus infection. We generated 293T and
HeLa cells with PDZD8 expression knocked out in a stable fashion,
using CRISPR-CAS9 gene editing technology. Rabbit antisera
against human PDZD8 were used to demonstrate a lack of dete-
ctable PDZD8 expression, and disruption of the pdzd8 coding
capacity was documented in the PDZD8 KO cells. Although no
experiment can rule out a role for PDZD8 in retroviral infection in
any circumstance, our results demonstrate that HIV-1 and MLV can
negotiate early infection efﬁciently in the complete absence of
PDZD8. Thus, PDZD8 is not absolutely essential for HIV-1 infection.
If PDZD8 interaction with the retroviral capsid contributes to HIV-
1 infectivity, redundancy in the cellular factors that mediate such
interaction must exist. Our results diminish the attractiveness of
PDZD8-capsid interaction as a potential target for intervention, as
HIV-1 and MLV can bypass any requirement for PDZD8 with
apparent ease.
Materials and methods
Cell lines and cell culture
293T and HeLa cells were obtained from the American Type
Culture Collection (ATCC). All cell lines were maintained in Dulbecco's
Modiﬁed Eagle Medium (Gibco) supplemented with 10% fetal calf
serum (FCS) (Invitrogen), and antibiotics (100 U/ml penicillin and
100 mg/ml streptomycin).
siRNA transfection
One day before transfection, cells were plated at a density of
1105 cells/well (293T) or 5104 cells/well (HeLa) in 24-well
plates. Anti-PDZD8 siRNA 21-mers siRNA-65 (Ambion, s42265) or
siRNA-67 (Ambion, s42267) were obtained from Life Technologies.
PDZD8 siRNAs at a concentration of 20 nM were transfected into
293T or HeLa cells with Lipofectamine RNAiMAX (Life technolo-
gies). Two days after transfection, cells were harvested.
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Plasmid construction
The sequence encoding human PDZD8438–663 was ampliﬁed by
PCR, and ligated into pGEX-4T-1 after digestion with BamHI and
XhoI. The PCR primer sequences were: forward: 50-GGATCCGGT-
GACCGAGTCCTGGTGTACTATGAAAGG-30, reverse: 50-CTCGAGTGA
AGTGACATCTTTGGCCACTTCTTGCTT-30.
The pX330-U6-Chimeric_BB-CBh-hSpCas9 (Plasmid: 42230) was
obtained from Addgene. The plasmid was digested with BbsI and
ligated with annealed protospacer oligo DNAs, following the proto-
col provided by Dr. Feng Zhang (Addgene). The constructed plas-
mids are designated pX330-gRNA1, pX330-gRNA2, and pX330-
gRNA3, respectively. The protospacer DNA oligonucleotides are:
Protospacer1 forward: CACCGATCCTGGCGTCGGCCGTGC, reverse:
AAACGCACGGCCGACGCCAGGATC; Protospacer2 forward: CACC-
GAGGCCGCCCGCGCGGGCGA, reverse: AAACTCGCCCGCGCGGGCGG
CCTC; Protospacer3 forward: CACCGTACCTTTATGGCGGCGGC, reve-
rse: AAACGCCGCCGCCATAAAGGTAC.
The genomic DNA template was prepared with a DNeasy Blood
& Tissue Kit (Qiagen). The PDZD8 homology arm was ampliﬁed
with a primer pair: forward: 50-1107GTCGACCACGCTCTCTGCAC-
CAGTGTTGGCATCTGT-1072-30, reverse: 50-866-GCGGCCGCCAATG
TCAAATTAGCACAGACCTGGGCT-831-30, and ligated with pGEM-T
easy vector (Promega); the resulting plasmid was named pGEM-T
Fig. 1. Elicitation of anti-PDZD8 antibody in rabbits. (A) Puriﬁcation of GST-PDZD8438–663. Glutathione–Sepharose 4B was used to purify GST-PDZD8438–663. The gel
comparing the puriﬁed GST-PDZD8438–663 protein with bovine serum albumin (BSA) was stained with Coomassie Blue. (B) Titration of PDZD8 antisera. PDZD8 antisera were
tested at the indicated dilutions for the ability to detect the expression of PDZD8 by Western blotting puriﬁed GST-PDZD8438–663 and lysates of 293T cells transfected with a
plasmid expressing PDZD8-ﬂag (Henning et al., 2010), or with an empty vector control.(C) Determination of endogenous PDZD8 in 293T and HeLa cells. PDZD8 siRNAs were
transfected into 293T cells, and the lysates were subjected to Western blotting for determination of endogenous PDZD8 expression. The Nctl-siRNA represents a negative
control siRNA, and the siRNA-65 and siRNA-67 are PDZD8-speciﬁc siRNAs (catalog numbers s42265 and s42267, respectively (Ambion)). (D) Immunoprecipitation (IP) of
PDZD8 with rabbit antisera. 293T cells were lysed with IP lysis buffer (Thermo). Cell lysates were incubated with PDZD8 antisera (or with a negative control (ctl) serum) and
Protein A-agarose beads (Sigma). The precipitated PDZD8 protein was detected by Western blotting with antiserum 1.
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easy-arm. The ﬁrst base of the pdzd8 open reading frame is
considered þ1, and the upstream sequence, starting with 1, is
designated in reverse order. A BamHI site was introduced into the
homology arm with a Q5s Site-Directed Mutagenesis Kit using
the following pair of primers: forward: 50-ggatccCTGCTGCTCAT-
GATCCTGGCGTCG-30, reverse: 50-CCCCATCCCGCCACCGCC-30. The
GFP-2A-Puromycin cassette was ampliﬁed from the template
OCT4-eGFP-2A-Puro from Addgene (Plasmid: 31939), using the
primer pair: forward: 50-GGATCCGTGAGCAAGGGCGAGGAGCTGTT-
CACCGGG-30, reverse: 50-GGATCCATCAGGCACCGGGCTTGCGGGT-
CATGCACC-30. The GFP-2A-Puromycin cassette was inserted into
the homology arm using the BamHI restriction site; the resulting
plasmid was named pGEM-T easy-armPG.
Expression and puriﬁcation of GST-PDZD8438–663
The pGEX-4T-1-PDZD8438–663 plasmid was transfected into E.
coli BL-21(DE3) (Life Technologies), and the bacteria were induced
for expression with 0.5 mM IPTG at 37 1C for 2 h. After induction,
the cells were harvested by centrifugation for 15 min at 5000g at
4 1C, and washed once with 1 PBS. Cells were resuspended in
5 packed cell volumes of 1 PBS with 1 mM EDTA and protease
inhibitor cocktail (Roche) and lysed by sonication. Cell lysates were
centrifuged at 12,000g for 15 min at 4 1C. The supernatant was
incubated with 1 PBS-equilibrated Glutathione–Sepharose 4B
(GE) at room temperature for 1 h by gentle rocking, and loaded
onto a Poly-Prep Chromatography Column (BIO-RAD). The beads
were washed with a total of 15 bed volumes of 1 PBS, with 5 bed
volumes of 1 PBS each time. To elute the protein from the
column, 1 bed volume of elution buffer (50 mM Tris HCl, 10 mM
reduced glutathione, pH 8.0) was added to the column and
incubated at room temperature for 10 min. Then, the elution
buffer was allowed to ﬂow through by gravity. In total, 5 bed
volumes of elution buffer were used to elute the GST-PDZD8438–663
protein.
Screening of PDZD8 knockout cells
Plasmids were prepared with the MaxiPrep kit (Qiagen). One
day before transfection, 8106 293T or 4106 HeLa cells were
seeded into a 10-cm dish. 15 μg of pX330-Protospacer1 and 5 μg of
linearized pGEM-T-ArmGP were co-transfected into 293T or HeLa
cells with Lipofectamine 3000 (Life Technologies). Before transfec-
tion, the medium for HeLa cells was changed to Opti-MEM (Gibco),
Fig. 2. Establishment of PDZD8 Knockout 293T and HeLa cell lines. (A) Design of the PDZD8 homology arm and selection of protospacer sequences for PDZD8 knock out by
CRISPR-CAS9. (B) Determination of PDZD8 expression in 293T and HeLa cell lines. The 293T cells and HeLa cells were transfected with pGEM-T-ArmGP and pX330-gRNA1,
pX330-gRNA2 or pX330-gRNA3, and selected with 0.4 μg/ml puromycin. The puromycin-resistant cells were lysed and the cell lysates were subjected to Western blotting
with a rabbit anti-PDZD8 antiserum to determine PDZD8 expression. HeLa cells transfected with a negative control (Nctl) siRNA or the PDZD8-speciﬁc siRNA-65 are shown
for comparison. gRNA1: pX330-gRNA1; gRNA2: pX330-gRNA2; gRNA3: pX330-gRNA3. (C) Clones of 293T cells prepared by serial dilution were examined for PDZD8
expression by Western blotting with rabbit anti-PDZD8 antiserum 1. Control 293T cells were transfected with the anti-PDZD8 siRNA-65 or with a negative control siRNA
(Nctl-siRNA). (D) Sequence of the pdzd8 gene in PDZD8 knockout (KO) 293T cell lines. Clones of PDZD8 KO cells were screened by serial dilution. Genomic DNA of PDZD8 KO
clones was prepared and the pdzd8 region was ampliﬁed with Q5 DNA polymerase by nested PCR. In the upper left panel, the region between 1107 and 866 of the pdzd8
gene was ampliﬁed; the product was puriﬁed and served as a template to amplify the region between 267and 481 of the gene, the product of which was analyzed on a 1%
agarose gel (upper right panel). The pGEM-T easy-arm (arm) and pGEM-T easy-armPG (armþpuroGFP) DNAs were included as PCR controls. The ampliﬁed DNA fragments
were sequenced along with the wild-type genome as a control. DB: database entry.
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and the next day the medium was changed to Dulbecco's Modiﬁed
Eagle Medium (Gibco) supplemented with 10% FCS (Invitrogen)
and antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin).
Three days after transfection, 0.4 μg/ml puromycin was added
to the cells for selection. To obtain single clones of PDZD8-
knockout cells, serial dilution was performed to achieve a cell
density of 1 cell/300 μl medium, and a 100-μl aliquot was seeded
into each well of a 96-well plate.
The pdzd8 gene of expanded single clones was sequenced.
A genomic DNA template was prepared using a DNeasy Blood
& Tissue Kit (Qiagen). The PDZD8 gene was ampliﬁed by nested
PCR with two pairs of primers: forward: 50-1107-GTCGACCAC-
GCTCTCTGCACCAGTGTTGGCATCTGT-1072-30, reverse: 50-866-GCG-
GCCGCCAATGTCAAATTAGCACAGACCTGGGCT-831-30; forward: 50-
267-AATGAGTGGAGGCCTGAGGGAG-246-30, reverse: 50-481-GGA-
TGGTCTTGATGAAGGGCAC-460-30. DNA fragments were puriﬁed
with a Gel extraction kit (Qiagen) and used for sequencing.
Infection with viruses expressing GFP
Recombinant HIV-1 vectors expressing green ﬂuorescent protein
(GFP) (HIV-1-GFP) were prepared by cotransfecting 293T cells in a
175-mm dish with 13 μg of pHIVvec2.GFP, 13 μg of pCMVgag/pol, and
13 μg of pVPack-VSV-G. The Moloney murine leukemia virus vector
expressing GFP (MLV-GFP) was prepared by cotransfecting 293T cells
in a 175-mm dish with 17.5 μg of pFB-hrGFP, 17.5 μg of pVPack-GFP,
and 4.7 μg of pVPack-VSV-G (all from Stratagene). Forty-eight hours
after transfection, medium containing recombinant viruses was har-
vested and ﬁltered (0.45-μm pore size).
Cells were plated at a density of 1105 cells/well (293T) or 5104
cells/well (HeLa) in 24-well plates. Medium containing recombinant
HIV-1-GFP or MLV-GFP vectors was added in serial dilutions to the
cells, which were incubated at 37 1C for 2 days. Cells were then
trypsinized, and analyzed by ﬂuorescence-activated cell sorting (FACS;
Becton Dickinson FACscan). GFP signals were analyzed by Flowjo, and
represented by geometric mean values.
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Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2015.01.034.
Fig. 3. Effect of PDZD8 knockout (KO) on HIV-1 and MLV infection. Wild-type (wt) or PDZD8 KO 293T (A) or HeLa (C) cells were incubated with various amounts of HIV-GFP
or MLV-GFP. GFP signals were determined by ﬂow cytometry and are represented as geometric mean values. The results of a typical experiment are shown. Similar results
were obtained in three independent experiments. The expression of PDZD8 in 293T (B) or HeLa (D) cells was determined by Western blotting cell lysates with rabbit anti-
PDZD8 antiserum 1.
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